IL-31 monoclonal antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IL-31 monoclonal antibody, covering 2015-08-19 to 2015-08-19. Get the full timeline:
Most recent: Clinical Trial Update: A Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic Dermatitis [Phase 1]